Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 11/20 | 0.57 |
| ▸ | CSNK1A1 | P48729 | 3/20 | 0.51 |
| ▸ | IKZF2 | Q9UKS7 | 9/20 | 0.49 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.47 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.47 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.47 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30797106 | 0.91 | CRBN (0.63) | CRBNCSNK1A1IKZF2IKZF1 | |
| SCHEMBL30797153 | 0.88 | CRBN (0.60) | CRBNCSNK1A1IKZF2DDB1IKZF3 | |
| SCHEMBL30797199 | 0.87 | CRBN (0.51) | CRBNCSNK1A1IKZF2IKZF1 | |
| SCHEMBL30797239 | 0.84 | CRBN (0.55) | CRBNCSNK1A1IKZF2 | |
| SCHEMBL30797273 | 0.84 | CRBN (0.64) | CRBNCSNK1A1IKZF2DDB1IKZF3 | |
| SCHEMBL30797095 | 0.83 | CRBN (0.58) | CRBNCSNK1A1IKZF2 | |
| SCHEMBL30797107 | 0.83 | CRBN (0.58) | CRBNIKZF2 | |
| SCHEMBL30797280 | 0.82 | CRBN (0.60) | CRBNCSNK1A1IKZF2 | |
| SCHEMBL22703752 | 0.82 | CRBN (0.73) | CRBNCSNK1A1IKZF2 | |
| SCHEMBL22703743 | 0.82 | CRBN (0.73) | CRBNCSNK1A1IKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023244817-A1 | SUBSTITUTED PIPERIDINES AS CK1A DEGRADERS | MONTE ROSA THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |